Patients were identified as candidates for FMT if
they had 2 recurrences of CDI, defined by continued
diarrhea (>3 loose stools a day) or positive C difficile
stool sample after finishing appropriate courses of
antibiotics (metronidazole, vancomycin, or fidaxomicin),
or if they had life-threatening illness from CDI
requiring hospitalization and/or admission to an
intensive care unit (ICU). We did not treat patients
with positive stool samples if they did not have
continued diarrhea. Once a potential candidate for